GRLF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.14259754172508E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.72799999995388E-06 |
Normal-vs-Stage2 |
5.09679998206281E-09 |
Normal-vs-Stage3 |
9.99200722162641E-16 |
Normal-vs-Stage4 |
2.12752038208919E-12 |
Stage1-vs-Stage2 |
7.055600E-03 |
Stage1-vs-Stage3 |
6.3572999975392E-08 |
Stage1-vs-Stage4 |
2.01949999999451E-05 |
Stage2-vs-Stage3 |
3.505800E-01 |
Stage2-vs-Stage4 |
3.584800E-01 |
Stage3-vs-Stage4 |
9.066800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.0962998004137E-10 |
Normal-vs-AfricanAmerican |
7.77680000396686E-08 |
Normal-vs-Asian |
2.474400E-02 |
Caucasian-vs-AfricanAmerican |
5.082800E-01 |
Caucasian-vs-Asian |
8.808000E-01 |
AfricanAmerican-vs-Asian |
6.864600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.3239997986858E-10 |
Normal-vs-Female |
5.83409998089479E-09 |
Male-vs-Female |
3.727200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.47919999996071E-06 |
Normal-vs-Age(41-60Yrs) |
2.18279999630866E-08 |
Normal-vs-Age(61-80Yrs) |
1.24580346039238E-11 |
Normal-vs-Age(81-100Yrs) |
1.96949999975438E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.362200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.685600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.394600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.059420E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.034200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.869200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.582000E-01 |
Normal-vs-Grade 2 |
2.40440000021103E-07 |
Normal-vs-Grade 3 |
4.99299490641647E-11 |
Normal-vs-Grade 4 |
1.67676983409137E-12 |
Grade 1-vs-Grade 2 |
1.531700E-02 |
Grade 1-vs-Grade 3 |
1.415410E-03 |
Grade 1-vs-Grade 4 |
1.64668999999007E-05 |
Grade 2-vs-Grade 3 |
2.108500E-02 |
Grade 2-vs-Grade 4 |
7.75620000000865E-05 |
Grade 3-vs-Grade 4 |
2.521700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.2516000000088E-05 |
Normal-vs-ccB subtype |
9.41913214091983E-12 |
ccA subtype-vs-ccB subtype |
3.52240000000004E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.78159717481685E-11 |
Normal-vs-N1 |
3.04860000022167E-07 |
N0-vs-N1 |
7.332200E-02 |
|
|